Evaluation of antibiotic effectiveness against Staphylococcus aureus surviving within the bovine mammary gland macrophage.
Bovine mastitis due to Staphylococcus aureus may become chronic and refractory to antibiotic therapy because of the organism's ability to survive within the mammary gland macrophages and/or polymorphonuclear neutrophils (PMNs). Therefore, phagocytosis and killing of S. aureus by bovine udder macrophages, udder and blood neutrophils and blood monocytes were studied. Gland and blood PMNs were about equally effective at phagocytosing (2.5 log reduction in supernatant) and killing the bacteria (92% reduction of viable bacteria by two hours). Gland macrophages phagocytosed at a lower rate (1.5 log reduction) and were less effective at killing the bacteria (73% reduction by two hours). Blood monocytes phagocytosed and killed S. aureus at the lowest rate. An udder macrophage monolayer system was developed and used to evaluate the ability of antibiotics to kill surviving intracellular S. aureus. This assay was similar to our previously described system with blood PMNs. Several classes of antibiotics were investigated. These included naphthalenic ansamycin, lincosaminide, tetracycline, coumarin, peptide, paulomycin, quinolone, macrolide, cephalosporin, and penicillin-class antibiotics. The activity of these compounds was compared to positive (rifampicin), negative (cloxacillin), and nonantibiotic treated controls. Only naphthalenic ansamycin class antibiotics, paulomycin, paldimycin and ciprofloxacin caused significant reduction in viable intracellular bacteria in the macrophage system. These results were similar to those obtained in the blood PMN monolayer system. Because a low intraphagolysosomal pH could affect an antibiotic's ability to kill intracellular bacteria by affecting the drug itself or inhibiting bacterial growth, the effect of low pH on the minimum inhibitory concentration and the minimum lethal concentration of clindamycin and rifampicin against three strains of S. aureus was also tested. While the activity of clindamycin at pH 5.0 compared to pH 7.0 was not affected greatly, the activity of rifampicin was greatly enhanced at acidic pH. These results suggest that at least some of the excellent activity of rifampicin for intracellular S. aureus is due to potentiation of its activity in the intracellular acidic compartment of the phagolysosome.
Sanchez
M S
MS
Upjohn Company, Kalamazoo, Michigan 49001.
Ford
C W
CW
Yancey
R J
RJ
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002417:Cattle; D002981:Clindamycin / Q000494:pharmacology; D005260:Female; D006863:Hydrogen-Ion Concentration; D008264:Macrophages / Q000382:microbiology*; D008321:Mammary Glands, Animal / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D010587:Phagocytosis; D012293:Rifampin / Q000494:pharmacology; D013211:Staphylococcus aureus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D002981:Clindamycin; D012293:Rifampin